Featured Products

My Quote Request

No products added yet

6505-00-767-9111

20 Products

NDC55390-0213-03

ACETYLCYSTEINE SOLUTION,USP

NSN, MFG P/N

6505007679111

NSN

6505-00-767-9111

View More Info

NDC55390-0213-03

ACETYLCYSTEINE SOLUTION,USP

NSN, MFG P/N

6505007679111

NSN

6505-00-767-9111

MFG

DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 PERCENTAGE, W/V ACETYLCYSTEINE ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ACETYLCYSTEINE SOLUTION USP 20% 10ML BT 3 BT PG
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 1 PLASTIC DROPPER PER BOX
TOTAL PRIMARY CONTAINER QUANTITY: 3

NDC00054-3028-02

ACETYLCYSTEINE SOLUTION,USP

NSN, MFG P/N

6505007679111

NSN

6505-00-767-9111

View More Info

NDC00054-3028-02

ACETYLCYSTEINE SOLUTION,USP

NSN, MFG P/N

6505007679111

NSN

6505-00-767-9111

MFG

BOEHRINGER INGELHEIM ROXANE INC. DIV SUB OF BOEHRINGER INGELHEIM CORP

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 PERCENTAGE, W/V ACETYLCYSTEINE ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ACETYLCYSTEINE SOLUTION USP 20% 10ML BT 3 BT PG
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 1 PLASTIC DROPPER PER BOX
TOTAL PRIMARY CONTAINER QUANTITY: 3

NDC00087-0570-03

ACETYLCYSTEINE SOLUTION,USP

NSN, MFG P/N

6505007679111

NSN

6505-00-767-9111

View More Info

NDC00087-0570-03

ACETYLCYSTEINE SOLUTION,USP

NSN, MFG P/N

6505007679111

NSN

6505-00-767-9111

MFG

MEAD JOHNSON & COMPANY DBA MEAD JOHNSON NUTRITIONALS

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 PERCENTAGE, W/V ACETYLCYSTEINE ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ACETYLCYSTEINE SOLUTION USP 20% 10ML BT 3 BT PG
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 1 PLASTIC DROPPER PER BOX
TOTAL PRIMARY CONTAINER QUANTITY: 3

NDC49502-0182-10

ACETYLCYSTEINE SOLUTION,USP

NSN, MFG P/N

6505007679111

NSN

6505-00-767-9111

View More Info

NDC49502-0182-10

ACETYLCYSTEINE SOLUTION,USP

NSN, MFG P/N

6505007679111

NSN

6505-00-767-9111

MFG

DEY LP

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 PERCENTAGE, W/V ACETYLCYSTEINE ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ACETYLCYSTEINE SOLUTION USP 20% 10ML BT 3 BT PG
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 1 PLASTIC DROPPER PER BOX
TOTAL PRIMARY CONTAINER QUANTITY: 3

A-METHAPRED

METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION,USP

NSN, MFG P/N

6505007683598

NSN

6505-00-768-3598

View More Info

A-METHAPRED

METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION,USP

NSN, MFG P/N

6505007683598

NSN

6505-00-768-3598

MFG

ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: EQUIVALENT TO 40 MG METHYLPREDNISOLONE ACTIVE INGREDIENT
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
FEATURES PROVIDED: DILUENT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1 ML. AFTER RECONSTITUTION
PRIMARY CONTAINER TYPE: BOTTLE, TWO COMPARTMENT

NDC00009-0113-01

METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION,USP

NSN, MFG P/N

6505007683598

NSN

6505-00-768-3598

View More Info

NDC00009-0113-01

METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION,USP

NSN, MFG P/N

6505007683598

NSN

6505-00-768-3598

MFG

PHARMACIA & UPJOHN COMPANY

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: EQUIVALENT TO 40 MG METHYLPREDNISOLONE ACTIVE INGREDIENT
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
FEATURES PROVIDED: DILUENT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1 ML. AFTER RECONSTITUTION
PRIMARY CONTAINER TYPE: BOTTLE, TWO COMPARTMENT

NDC00009-0113-12

METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION,USP

NSN, MFG P/N

6505007683598

NSN

6505-00-768-3598

View More Info

NDC00009-0113-12

METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION,USP

NSN, MFG P/N

6505007683598

NSN

6505-00-768-3598

MFG

PHARMACIA & UPJOHN COMPANY

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: EQUIVALENT TO 40 MG METHYLPREDNISOLONE ACTIVE INGREDIENT
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
FEATURES PROVIDED: DILUENT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1 ML. AFTER RECONSTITUTION
PRIMARY CONTAINER TYPE: BOTTLE, TWO COMPARTMENT

NDC00074-5684-01

METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION,USP

NSN, MFG P/N

6505007683598

NSN

6505-00-768-3598

View More Info

NDC00074-5684-01

METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION,USP

NSN, MFG P/N

6505007683598

NSN

6505-00-768-3598

MFG

ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: EQUIVALENT TO 40 MG METHYLPREDNISOLONE ACTIVE INGREDIENT
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
FEATURES PROVIDED: DILUENT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1 ML. AFTER RECONSTITUTION
PRIMARY CONTAINER TYPE: BOTTLE, TWO COMPARTMENT

SOLU-MEDROL

METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION,USP

NSN, MFG P/N

6505007683598

NSN

6505-00-768-3598

View More Info

SOLU-MEDROL

METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION,USP

NSN, MFG P/N

6505007683598

NSN

6505-00-768-3598

MFG

PHARMACIA & UPJOHN COMPANY

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: EQUIVALENT TO 40 MG METHYLPREDNISOLONE ACTIVE INGREDIENT
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
FEATURES PROVIDED: DILUENT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1 ML. AFTER RECONSTITUTION
PRIMARY CONTAINER TYPE: BOTTLE, TWO COMPARTMENT

3021

TALC,USP

NSN, MFG P/N

6505007691048

NSN

6505-00-769-1048

View More Info

3021

TALC,USP

NSN, MFG P/N

6505007691048

NSN

6505-00-769-1048

MFG

JOHNSON & JOHNSON SALES AND LOGISTICS COMPANY LLC

Description

PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 9.000 OUNCES
PRIMARY CONTAINER TYPE: CAN

MERTHIOLATE

THIMEROSAL TINCTURE,USP

NSN, MFG P/N

6505007691254

NSN

6505-00-769-1254

View More Info

MERTHIOLATE

THIMEROSAL TINCTURE,USP

NSN, MFG P/N

6505007691254

NSN

6505-00-769-1254

MFG

ELI LILLY AND COMPANY DBA ELI LILLY

Description

PRIMARY CONTAINER CONTENT QUANTITY: 1.000 PINTS
PRIMARY CONTAINER TYPE: BOTTLE

NDC00002-2579-05

THIMEROSAL TINCTURE,USP

NSN, MFG P/N

6505007691254

NSN

6505-00-769-1254

View More Info

NDC00002-2579-05

THIMEROSAL TINCTURE,USP

NSN, MFG P/N

6505007691254

NSN

6505-00-769-1254

MFG

ELI LILLY AND COMPANY DBA ELI LILLY

Description

PRIMARY CONTAINER CONTENT QUANTITY: 1.000 PINTS
PRIMARY CONTAINER TYPE: BOTTLE

SURGEXCREAM

DEPILATORY,SURGICAL

NSN, MFG P/N

6505007691327

NSN

6505-00-769-1327

View More Info

SURGEXCREAM

DEPILATORY,SURGICAL

NSN, MFG P/N

6505007691327

NSN

6505-00-769-1327

MFG

COOPER LABORATORIES INC

Description

DESIGN CONTROL REFERENCE: SURGEXCREAM
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 100 GM,UNIT QTY,TUBE
MANUFACTURERS CODE: 51870
REFERENCE NUMBER DIFFERENTIATING CHARACTERISTICS: TEXT
THE MANUFACTURERS DATA:

ELAVIL

AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP

NSN, MFG P/N

6505007702061

NSN

6505-00-770-2061

View More Info

ELAVIL

AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP

NSN, MFG P/N

6505007702061

NSN

6505-00-770-2061

MFG

ZENECA INC ZENECA PHARMACEUTICALS GROUP STUART PHARMACEUTICALS

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS AMITRIPTYLINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMITRIPTYLINE HYDROCHLORIDE TABLETS USP 50MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: ENDEP BY ROCHE

ENDEP

AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP

NSN, MFG P/N

6505007702061

NSN

6505-00-770-2061

View More Info

ENDEP

AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP

NSN, MFG P/N

6505007702061

NSN

6505-00-770-2061

MFG

HOFFMANN-LA ROCHE INC.

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS AMITRIPTYLINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMITRIPTYLINE HYDROCHLORIDE TABLETS USP 50MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: ENDEP BY ROCHE

NDC00038-0041-10

AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP

NSN, MFG P/N

6505007702061

NSN

6505-00-770-2061

View More Info

NDC00038-0041-10

AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP

NSN, MFG P/N

6505007702061

NSN

6505-00-770-2061

MFG

ZENECA INC ZENECA PHARMACEUTICALS GROUP STUART PHARMACEUTICALS

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS AMITRIPTYLINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMITRIPTYLINE HYDROCHLORIDE TABLETS USP 50MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: ENDEP BY ROCHE

NDC00054-4043-25

AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP

NSN, MFG P/N

6505007702061

NSN

6505-00-770-2061

View More Info

NDC00054-4043-25

AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP

NSN, MFG P/N

6505007702061

NSN

6505-00-770-2061

MFG

BOEHRINGER INGELHEIM ROXANE INC. DIV SUB OF BOEHRINGER INGELHEIM CORP

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS AMITRIPTYLINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMITRIPTYLINE HYDROCHLORIDE TABLETS USP 50MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: ENDEP BY ROCHE

NDC00140-0109-01

AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP

NSN, MFG P/N

6505007702061

NSN

6505-00-770-2061

View More Info

NDC00140-0109-01

AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP

NSN, MFG P/N

6505007702061

NSN

6505-00-770-2061

MFG

HOFFMANN-LA ROCHE INC.

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS AMITRIPTYLINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMITRIPTYLINE HYDROCHLORIDE TABLETS USP 50MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: ENDEP BY ROCHE

NDC00182-1020-01

AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP

NSN, MFG P/N

6505007702061

NSN

6505-00-770-2061

View More Info

NDC00182-1020-01

AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP

NSN, MFG P/N

6505007702061

NSN

6505-00-770-2061

MFG

GOLDLINE LABORATORIES GOVERNMENT SALES DIV

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS AMITRIPTYLINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMITRIPTYLINE HYDROCHLORIDE TABLETS USP 50MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: ENDEP BY ROCHE

NDC00228-2133-10

AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP

NSN, MFG P/N

6505007702061

NSN

6505-00-770-2061

View More Info

NDC00228-2133-10

AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP

NSN, MFG P/N

6505007702061

NSN

6505-00-770-2061

MFG

ACTAVIS INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS AMITRIPTYLINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMITRIPTYLINE HYDROCHLORIDE TABLETS USP 50MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: ENDEP BY ROCHE